Literature DB >> 16698314

Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid.

Ernst Malle1, Gunther Marsche, Jürgen Arnhold, Michael J Davies.   

Abstract

Substantial evidence supports the notion that oxidative processes contribute to the pathogenesis of atherosclerosis and coronary heart disease. The nature of the oxidants that give rise to the elevated levels of oxidised lipids and proteins, and decreased levels of antioxidants, detected in human atherosclerotic lesions are, however, unclear, with multiple species having been invoked. Over the last few years, considerable data have been obtained in support of the hypothesis that oxidants generated by the heme enzyme myeloperoxidase play a key role in oxidation reactions in the artery wall. In this article, the evidence for a role of myeloperoxidase, and oxidants generated therefrom, in the modification of low-density lipoprotein, the major source of lipids in atherosclerotic lesions, is reviewed. Particular emphasis is placed on the reactions of the reactive species generated by this enzyme, the mechanisms and sites of damage, the role of modification of the different components of low-density lipoprotein, and the biological consequences of such oxidation on cell types present in the artery wall and in the circulation, respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16698314     DOI: 10.1016/j.bbalip.2006.03.024

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  56 in total

Review 1.  The electrophile responsive proteome: integrating proteomics and lipidomics with cellular function.

Authors:  Ashlee N Higdon; Aimee Landar; Stephen Barnes; Victor M Darley-Usmar
Journal:  Antioxid Redox Signal       Date:  2012-04-18       Impact factor: 8.401

Review 2.  Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models.

Authors:  Jennifer Rivera; Christopher G Sobey; Anna K Walduck; Grant R Drummond
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

Review 3.  Candidate biomarkers for the detection of coronary plaque destabilization and rupture.

Authors:  Anand Prasad; Sotirios Tsimikas
Journal:  Curr Atheroscler Rep       Date:  2008-08       Impact factor: 5.113

4.  Effects of increasing docosahexaenoic acid intake in human healthy volunteers on lymphocyte activation and monocyte apoptosis.

Authors:  Saïda Mebarek; Natalia Ermak; Amal Benzaria; Stéphanie Vicca; Madeleine Dubois; Georges Némoz; Martine Laville; Bernard Lacour; Evelyne Véricel; Michel Lagarde; Annie-France Prigent
Journal:  Br J Nutr       Date:  2008-08-19       Impact factor: 3.718

5.  Role of VPO1, a newly identified heme-containing peroxidase, in ox-LDL induced endothelial cell apoptosis.

Authors:  Yong-Ping Bai; Chang-Ping Hu; Qiong Yuan; Jun Peng; Rui-Zheng Shi; Tian-Lun Yang; Ze-Hong Cao; Yuan-Jian Li; Guangjie Cheng; Guo-Gang Zhang
Journal:  Free Radic Biol Med       Date:  2011-07-19       Impact factor: 7.376

6.  Effects of oxidation on structural stability and remodeling of human very low density lipoprotein.

Authors:  Madhumita Guha; Olga Gursky
Journal:  Biochemistry       Date:  2010-11-09       Impact factor: 3.162

Review 7.  Cytochrome c/cardiolipin relations in mitochondria: a kiss of death.

Authors:  Valerian E Kagan; Hülya A Bayir; Natalia A Belikova; Olexandr Kapralov; Yulia Y Tyurina; Vladimir A Tyurin; Jianfei Jiang; Detcho A Stoyanovsky; Peter Wipf; Patrick M Kochanek; Joel S Greenberger; Bruce Pitt; Anna A Shvedova; Grigory Borisenko
Journal:  Free Radic Biol Med       Date:  2009-03-12       Impact factor: 7.376

Review 8.  The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.

Authors:  Garry G Graham; Michael J Davies; Richard O Day; Anthoulla Mohamudally; Kieran F Scott
Journal:  Inflammopharmacology       Date:  2013-05-30       Impact factor: 4.473

9.  Hypochlorite-modified high-density lipoprotein acts as a sink for myeloperoxidase in vitro.

Authors:  Gunther Marsche; Paul G Furtmüller; Christian Obinger; Wolfgang Sattler; Ernst Malle
Journal:  Cardiovasc Res       Date:  2008-02-23       Impact factor: 10.787

Review 10.  Myeloperoxidase: a target for new drug development?

Authors:  E Malle; P G Furtmüller; W Sattler; C Obinger
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.